Get the Stockscreener App
4.19
10.28%
-0.48
After Hours:
4.30
0.11
+2.63%
Aclarion Inc Stock (ACON) Latest News
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body - OrthoSpineNews
Understanding ACON stock ratios for better investment decisions - US Post News
Aclarion stock hits 52-week low at $4.41 amid steep annual decline - Investing.com India
Aclarion Wins Patent, Shares Eke Up - Baystreet.ca
Aclarion secures patent for infection, pain biomarker detection By Investing.com - Investing.com South Africa
Aclarion secures patent for infection, pain biomarker detection - Investing.com India
Aclarion, Inc. Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy Data Processing to Identify Pain and Infection Biomarkers Throughout the Body - Marketscreener.com
Analyzing the Price-to-Earnings Ratio of Aclarion Inc (ACON) - The News Heater
Aclarion Announces Northwestern Medicine as Initial Site for Pivotal CLARITY Trial Evaluating Nociscan for Low Back Pain Treatment - Nasdaq
Aclarion, Inc. Announces Northwestern Medicine as First CLARITY Trial Site -February 06, 2025 at 07:23 am EST - Marketscreener.com
Stocks of Aclarion Inc (ACON) are poised to climb above their peers - SETE News
Aclarion secures funding for pivotal CLARITY trial By Investing.com - Investing.com South Africa
Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded - OrthoSpineNews
12 AI News and Ratings You Should Not Miss - Insider Monkey
What's Going On With Aclarion Stock Tuesday? - Benzinga
Investor Confidence Grows As Aclarion (ACON) Secures Funding For CLARITY Trial - Stocks Telegraph
Aclarion secures funding for pivotal CLARITY trial - Investing.com
Aclarion Secures $20M Funding for Game-Changing Chronic Back Pain Trial - StockTitan
Riding the Waves: A Guide to Investing in ACON Stock - The InvestChronicle
NOCISCAN touted as lumbar pain diagnostic advance - MSN
Aclarion, Inc. Enters into Securities Purchase Agreement for Registered Direct Offering - Defense World
Aclarion’s Retail Following Jumps 60% After Reverse Stock Split As Micro-Cap Health Tech Shares Nearly Double - MSN
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference - OrthoSpineNews
NOCISCAN touted as lumbar pain diagnostic advance By Investing.com - Investing.com UK
Game-Changing AI Spine Pain Detection Tech Gets Major Spotlight at Premier Medical Conference - StockTitan
Aclarion, Inc. Announces Securities Purchase Agreement - TipRanks
Aclarion announces reverse stock split effective January 29 - MSN
Aclarion announces reverse stock split effective January 29 By Investing.com - Investing.com Australia
Aclarion Announces $4.7 Million Registered Direct Stock Offering - citybuzz -
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market - Yahoo Finance
Stock market news: Aclarion plunged by 99.50% while Foxx Development surged by 221.11% during mid day trading - Business Upturn
Stock market today: Aclarion -99.69%, CARGO Therapeutics -76.31% among biggest losers in early trading - Business Upturn
Stock market today: Aclarion plunged by 99.72% while Crown Electrokinetics was down by 99.52% in early trading - Business Upturn
Aclarion Takes Bold Step: Executes 1-for-370 Reverse Stock Split to Boost Market Position - The Africa Logistics
Aclarion Announces Updated Product Release That Expands Mri Scanner Access for Nociscan Solution - Marketscreener.com
Aclarion, Inc. Announces First Commercial Agreement in Michigan -August 14, 2024 at 08:08 am EDT - Marketscreener.com
Aclarion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Aclarion, Inc. George Frey MD as Key Opinion Leader -January 17, 2023 at 08:29 am EST - Marketscreener.com
Aclarion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 - Marketscreener.com
Aclarion, Inc. announced that it has received $1 million in funding -September 29, 2024 - Marketscreener.com
Aclarion Launches Surgeon Partnership to Apply Nociscan's Ai Technology to Personal Injury and Workers Compensation Market - Marketscreener.com
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - Marketscreener.com
Stock market news: Aclarion plunged by 99.74% while Signing Day Sports surged by 125.77% during mid day trading - Business Upturn
Stock market today: Aclarion declined by 99.74% while Ocean Biomedical surged by 27.94% in early trading - Business Upturn
Aclarion stock plunges to 52-week low, touches $0.03 - MSN
Aclarion announces revised reverse stock split details By Investing.com - Investing.com South Africa
Aclarion stock plunges to 52-week low, touches $0.03 By Investing.com - Investing.com South Africa
1.00%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):